Daewoong Pharmaceutical unveils 'Innovative Drug Delivery Technologies' in Milan-From world's first microneedle therapy to once-a-month obesity treatment
October 10, 2024 | 05:16
Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae Lee) announced on the 9th that they will present their cutting-edge drug delivery technologies, including the world's first microneedle-based drugs, at 'CPHI Worldwide 2024' the world's largest pharmaceutical and biotech exhibition held in Milan, Italy .
Mobile Version